60nm Reactant Free Silver Nanoparticles

When nanoparticle conjugation, electron microscopy, toxicity studies, and multiplex assay development require a well-defined nanoparticle reagent, the 60 nm reactant-free silver nanoparticles format helps procurement and lab teams identify the relevant material and functional configuration.

Silver nanoparticles provide a plasmonic alternative to gold nanoparticles, with optical behavior useful for biosensing, multiplex assay development and materials-oriented studies where those applications are listed in the product data.

The reactant-free format is useful when sensitive downstream workflows require minimized residual manufacturing reactants. It should be compared with standard, stabilized or endotoxin-free versions according to the application and formulation requirements of the experiment.

The supplied description emphasizes controlled size distribution and defined particle morphology. Those details matter when comparing related nanoparticle products for optical response, conjugation behavior or assay consistency.

The application profile includes nanoparticle conjugation, electron microscopy, toxicity studies, multiplex assay development, and blotting workflows. These terms reflect the supported scientific workflows for this listing and help scientists compare related products by use case, not by material alone.

This mid-to-large nanoparticle size can be useful when stronger optical contrast or more particle surface area is desired.

For silver nanoparticle workflows, compare citrate, biotin, carboxyl and methoxy-PEG formats according to whether the experiment needs optical signal, covalent coupling, streptavidin binding or reduced non-specific binding.

For procurement and product selection, compare it with related nanoparticles by particle size, surface chemistry, formulation and listed application rather than treating all nanoparticles as interchangeable.

Application areas

• Nanoparticle conjugation with supported proteins, ligands or biomolecules
• Electron microscopy labeling and contrast workflows
• Toxicity, nanotoxicology or exposure-response studies where listed
• Multiplex assay development using distinct optical nanoparticle signals
• Blotting workflows using nanoparticle-based labels or conjugates